Litcius/Paper detail

The development of oral semaglutide, an oral GLP-1 analog, for the treatment of type 2 diabetes

Mads Frederik Rasmussen

2020Diabetology International53 citationsDOIOpen Access PDF

Topics & Concepts

SemaglutideLiraglutideMedicineDulaglutideSitagliptinEmpagliflozinPlaceboType 2 diabetesGlycemicSitagliptin PhosphateDiabetes mellitusInternal medicinePharmacologyEndocrinologyAlternative medicinePathologyDiabetes Treatment and ManagementMetabolism, Diabetes, and CancerDiabetes Management and Research
The development of oral semaglutide, an oral GLP-1 analog, for the treatment of type 2 diabetes | Litcius